Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

Author： Lebens M.   Holmgren J.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.14, Iss.13, 1996-09, pp. : 1299-1299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Mizokami M.   Kozuka S.   Taniguchi T.   Matano K.   Maeyama J.-i.   Mizuno K.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1460-1466

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children

By Qadri F.   Wenneras C.   Ahmed F.   Asaduzzaman M.   Saha D.   Albert M.J.   Sack R.B.   Svennerholm A.-M.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2704-2712

Elsevier

Access to resources Recommend Favorite

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant

By Wu H.-Y.   Russell M.W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 286-292

Elsevier

Access to resources Recommend Favorite

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

By Yasuda Y.   Isaka M.   Taniguchi T.   Zhao Y.   Matano K.   Matsui H.   Morokuma K.   Maeyama J.-i.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2954-2963

Elsevier

Access to resources Recommend Favorite

Enhancement of the immune response to non-replicating herpes simplex virus type-1 preparations by mucosal administration in the presence of cholera toxin

By Richards C.M.   Hill T.J.   Williams N.A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1065-1069

Elsevier

Access to resources Recommend Favorite